Wonbiogen

Wonbiogen plans to build a dedicated production plant for hydrocolloid products at its headquarters, along with new facilities for medical device cosmetics and functional cosmetics.

Wonbiogen completed US FDA registration for hydrocolloid wound dressing products, enabling export expansion to North America. The company is negotiating supply contracts with US companies and plans to build a dedicated production plant.